Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

25TFM-NBOMe

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
25TFM-NBOMe
Clinical data
Other namesNBOMe-2C-TFM; 2C-TFM-NBOMe; Cimbi-138
Drug classSerotonin5-HT2 receptoragonist;Serotonergic psychedelic;Hallucinogen
Identifiers
  • 2-(4-trifluoromethyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC19H22F3NO3
Molar mass369.384 g·mol−1
3D model (JSmol)
  • FC(F)(F)c1c(OC)cc(c(OC)c1)CCNCc2ccccc2OC
  • InChI=1S/C19H22F3NO3/c1-24-16-7-5-4-6-14(16)12-23-9-8-13-10-18(26-3)15(19(20,21)22)11-17(13)25-2/h4-7,10-11,23H,8-9,12H2,1-3H3 checkY
  • Key:FBHVTQIAHOTPAM-UHFFFAOYSA-N checkY
  (verify)

25TFM-NBOMe (also known asNBOMe-2C-TFM,2C-TFM-NBOMe, andCimbi-138) is a derivative of thephenethylaminehallucinogen2C-TFM, discovered by Ralf Heim at theFree University of Berlin by 2000.[1][2] It can be taken to producepsychedelic effects similar to25I-NBOMe and25D-NBOMe.[citation needed]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Pharmacology

[edit]

Pharmacodynamics

[edit]
25TFM-NBOMe activities
TargetAffinity (Ki, nM)
5-HT1AND
5-HT1BND
5-HT1D1,817
5-HT1END
5-HT1FND
5-HT2A0.35–0.49 (Ki)
0.96–2.0 (EC50Tooltip half-maximal effective concentration)
80–92% (EmaxTooltip maximal efficacy)
5-HT2B1.1 (Ki)
ND (EC50)
ND (Emax)
5-HT2C2.7 (Ki) (rat)
11.5 (EC50)
110% (
Emax)
5-HT3ND
5-HT4ND
5-HT5A8,128
5-HT623.4
5-HT75,974
α1Aα1DND
α2Aα2CND
β1β3ND
D1D5ND
H1H4ND
M1M5ND
I1ND
σ1,σ2ND
ORsND
TAAR1Tooltip Trace amine-associated receptor 1ND
SERTTooltip Serotonin transporterND (Ki)
ND (IC50Tooltip half-maximal inhibitory concentration)
ND (EC50)
NETTooltip Norepinephrine transporterND (Ki)
ND (IC50)
ND (EC50)
DATTooltip Dopamine transporterND (Ki)
ND (IC50)
ND (EC50)
Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified.Refs:[3][4][5][6]

25TFM-NBOMe acts as apotentpartial agonist for theserotonin5-HT2A receptor, though its relative potency is disputed, with some studies finding it to be of lower potency than25I-NBOMe,[7][8] while others show it to be of similar or higher potency,[9] possibly because of differences in the assay used.[10]

History

[edit]

25TFM-NBOMe was first described in thescientific literature by Ralf Heim and colleagues at theFree University of Berlin by 2000.[1][2]

Society and culture

[edit]

Legal status

[edit]

United Kingdom

[edit]

This substance is aClass A drug in the United Kingdom as a result of theN-benzylphenethylamine catch-all clause in theMisuse of Drugs Act 1971.[11]

See also

[edit]

References

[edit]
  1. ^abHeim R, Pertz HH, Elz S (2000)."Partial 5-HT2A-receptor agonists of the phenylethanamine series: effect of a trifluoromethyl substituent".Arch. Pharm. Pharm. Med. Chem.333 (Supplement 2): 1.29.
  2. ^abHeim R (2004).Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts [Synthesis and pharmacology of potent 5-HT2A receptor agonists with N-2-methoxybenzyl substructure. Development of a new structure-activity relationship] (PhD thesis) (in German).
  3. ^Ettrup A (2010).Serotonin receptor studies in the pig brain: pharmacological intervention and positron emission tomography tracer development (Ph.D. thesis). Faculty of Health Sciences, University of Copenhagen.
  4. ^Hansen M (2010-12-16).Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain (Ph.D. thesis). University of Copenhagen.doi:10.13140/RG.2.2.33671.14245.
  5. ^Ettrup A, Hansen M, Santini MA, Paine J, Gillings N, Palner M, et al. (April 2011). "Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers".European Journal of Nuclear Medicine and Molecular Imaging.38 (4):681–693.doi:10.1007/s00259-010-1686-8.PMID 21174090.
  6. ^Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Bräuner-Osborne H, et al. (19 March 2014)."Synthesis and Structure–Activity Relationships of N -Benzyl Phenethylamines as 5-HT 2A/2C Agonists".ACS Chemical Neuroscience.5 (3):243–249.doi:10.1021/cn400216u.ISSN 1948-7193.PMC 3963123.PMID 24397362.
  7. ^Silva M (2009).Theoretical study of the interaction of agonists with the 5-HT2A receptor (PhD thesis). Universität Regensburg.
  8. ^Silva ME, Heim R, Strasser A, Elz S, Dove S (January 2011). "Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor".Journal of Computer-aided Molecular Design.25 (1):51–66.Bibcode:2011JCAMD..25...51S.CiteSeerX 10.1.1.688.2670.doi:10.1007/s10822-010-9400-2.PMID 21088982.S2CID 3103050.
  9. ^Ettrup A, Hansen M, Santini MA, Paine J, Gillings N, Palner M, et al. (April 2011). "Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers".European Journal of Nuclear Medicine and Molecular Imaging.38 (4):681–693.doi:10.1007/s00259-010-1686-8.PMID 21174090.S2CID 12467684.
  10. ^Hansen M (2010-12-16).Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain (Ph.D. thesis). University of Copenhagen.doi:10.13140/RG.2.2.33671.14245.
  11. ^"The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014".UK Statutory Instruments 2014 No. 1106. www.legislation.gov.uk.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=25TFM-NBOMe&oldid=1311562602"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp